Blue Jay Capital Management’s NEVRO CORP. NVRO Stock Holding History

Blue Jay Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$7.82M	Buy	105,000 +5,000	+5%	+$401K	5.33%	10
2017 Q1	$9.37M	Buy	+100,000	New	+$9.06M	4.61%	10
2016 Q1	–	Sell	-190,000	Closed	-$12.8M	–	25
2015 Q4	$12.8M	Buy	+190,000	New	+$10.2M	4.32%	8

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Blue Jay Capital Management's NVRO Position: Q2 2017 in Review

Blue Jay Capital Management increased its NEVRO CORP. (NVRO) stake by 5% in Q2 2017, buying an estimated $401K and bringing the position to 105,000 shares worth $7.82M. The position accounts for 5.33% of the portfolio, ranked #10.

Blue Jay Capital Management first reported a position in NVRO in Q4 2015 and has held it in 3 quarters since. The position peaked at $12.8M in Q4 2015. 201 funds tracked by Wall St. Rank hold NVRO as of Q2 2017.

Blue Jay Capital Management held 105,000 shares of NEVRO CORP. worth $7.82M as of Q2 2017.
Blue Jay Capital Management bought 5,000 NEVRO CORP. shares in Q2 2017, an estimated $401K.
NEVRO CORP. made up 5.33% of Blue Jay Capital Management's portfolio in Q2 2017, its #10 holding.
Blue Jay Capital Management first reported a position in NEVRO CORP. in Q4 2015 and has held it in 3 quarters since.
Blue Jay Capital Management's NEVRO CORP. position peaked at $12.8M in Q4 2015.
201 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.